ArticleBritish journal of clinical pharmacology2019

Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities-Which TKI is the safest?

Ahmet Emre EşkazanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.